Antonio Costa
Principal investigator, leads DIANT PHARMA INC.
BiotechFounder
Built from public records only: federal awards, patents, filings and papers.Is this you? Contact Noair Lab to claim this profile, correct it or hide it.
2022First federal award
$512KFederal grants as PI2 awards
0Patents grantedNone matched
0PapersOpenAlex
Federal awards and patents by year
AwardsPatents
2 awards · $512K
| Date | Agency | Award | Amount | Company |
|---|---|---|---|---|
| Feb 15, 2022 | NSF | SBIR Phase I SBIR Phase I:Continuous Manufacturing for Nucleic Acid Lipid Nanoparticles to Improve the Supply Chain of Therapeutics and Vaccines (COVID-19) | $256K | DIANT PHARMA INC |
| Feb 9, 2022 | NSF | SBIR Phase I SBIR Phase I: Continuous Manufacturing for Nucleic Acid Lipid Nanoparticles to Improve the Supply Chain of Therapeutics and Vaccines (COVID-19) | $256K | DIANT PHARMA INC |
Peer ranks
Federal funding#2,377
Awards as PI#1,252
Patents#273
Companies
- DIANT PHARMA INCLeads (SEC Form D) · Biotech
Federal awards through Oct 21, 2026 and patents through Oct 20, 2026. Awards come from NIH, NSF and other agency records that name a principal investigator; DoD and NASA contract awards do not, so they are not shown here. Researchers are matched by name and company.